Cardinal Health Financials - Benzinga

Cardinal Health Inc

CAHNYSE

Trade with Public

Trade with Public

$237.92

마지막 업데이트: Aug 25, 4:00 PM

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 옵션 주식 보고서

Cardinal Health Financials

Cardinal Health (CAH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Cardinal Health Analysts Increase Their Forecasts Following Q4 Results

Cardinal Health posted mixed Q4 results, with adjusted earnings of $2.91 per share beating estimates, but sales missing expectations. The company also raised its share repurchase authorization and expects strong earnings in fiscal 2027.

Avi Kapoor

S&P 500 Falls for Second Session Ahead of Inflation Report: Investor Sentiment Weakens, Fear & Greed Index Remains in ‘Greed’ Zone

CNN Fear & Greed Index: Market sentiment declined, but remained in Greed zone on Tuesday. Stocks closed lower.

Avi Kapoor

Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market

CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and approves a $5B buyback expansion.

Vandana Singh

US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results

US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.

Avi Kapoor

PRO
Cardinal Health Q4 Adj. EPS $2.91 Beats $2.42 Estimate, Sales $63.672B Miss $65.029B Estimate

Benzinga Newsdesk

PRO
Cardinal Health Sees FY2027 Adj EPS $12.40-$12.60 vs $12.04 Est

Cardinal Health (NYSE:CAH) is looking for FY2027 Adj EPS of $12.40-$12.60 vs $12.04 analyst estimate..

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved